ASPIRE BIOPHARMA HOLDINGS, INC. Cash and Restricted Cash
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Cash and Restricted Cash of $12.17 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.17M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.86M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.00M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.95M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $12.17M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.86M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.00M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.95M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $206.23K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.35M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $3.63K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $16.54K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $19.60K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $47.29K 10-Q/A · filed 2025-08-13 |
| 2023-12-31 | $11.17K S-1/A · filed 2026-04-10 |
| 2023-09-30 | $280.00 10-Q · filed 2024-11-14 |
| 2023-06-30 | $125.20K 10-Q · filed 2024-08-16 |
| 2023-03-31 | $315.15K 10-Q · filed 2024-06-05 |
| 2022-12-31 | $497.26K 10-K · filed 2025-04-07 |
| 2022-09-30 | $533.13K 10-Q · filed 2023-11-08 |
| 2022-06-30 | $579.75K 10-Q · filed 2023-08-08 |
| 2022-03-31 | $618.12K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |